Role of Fas ligand in uveal melanoma-induced liver damage

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 239, Issue 10, 2001, Pages 752-758

  Repp, A C ^a   Mayhew, E S ^a   Howard, K ^a   Alizadeh, H ^a   Niederkorn, J Y ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; LIPOCORTIN 5;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CONTACT; CELL DEATH; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER FAILURE; LIVER INJURY; LIVER METASTASIS; MELANOMA CELL; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UVEA MELANOMA;

EID: 0035171051     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004170100363     Document Type: Article

References (35)

1. Treatment of metastatic uveal melanoma: Review and recommendations
2. In vivo expression of Fas-Ligand in uveal melanoma
3. Human melanoma cells do not express Fas (Apo-1/CD95) ligand
4. Geometric control of cell life and death
5. Establishment and characterization of an uveal melanoma cell line
6. Metastatic uveal melanoma. Pretherapy serum liver enzyme and liver scan abnormalities
7. Metastatic patterns of choroidal melanoma
8. Technical comment
9. Fas ligand-induced apoptosis as a mechanism of immune privilege
10. Melanoma cell expression of Fas (Apo-1/CD95) ligand: Implications for tumor immune escape
11. Subretinal space and vitreous cavity as immunologically privileged sites for retinal allografts
12. Immunologic consequences of intraocular implantation of retinal pigment epithelial allografts
13. Characterization of uveal melanoma cell lines that grow as xenografts in rabbit eyes
14. Prognosis and treatment of disseminated uveal melanoma
15. A chicken embryo model to study the growth of human uveal melanoma
16. Efficacy of tumor-infiltrating lymphocytes in the treatment of hepatic metastases arising from transgenic intraocular tumors in mice
17. Role of epidermal growth factor in the metastasis of intraocular melanomas
18. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by over expression of Bcl-2 and Abl
19. Prognostic parameters in uveal melanoma: A review
20. CD95 ligand expression as a mechanism of immune escape in breast cancer
21. Deviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice
22. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
23. Lethal effect of the anti-Fas antibody in mice
24. Technical comment
25. An investigation into the association between liver damage and metastatic uveal melanoma
26. Survival in metastatic ocular melanoma
27. Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape
28. Contribution of Fas ligand to T cell-mediated hepatic injury in mice
29. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas
30. Technical note: Aberrant detection of cell surface Fas ligand with anti-peptide antibodies
31. Molecular cloning and expression of the Fas ligand; a novel member of the tumor necrosis factor family
32. Signals emanating from membrane Fas ligand control the release of cytoplasmic Fas ligand and the induction of apoptosis
33. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin V
34. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen
35. Fas/Fas ligand interaction in human colorectal hepatic metastases: A mechanism of hepatocyte destruction to facilitate local tumor invasion